A detailed history of Cornerstone Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cornerstone Advisory, LLC holds 2,545 shares of LLY stock, worth $1.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,545
Previous 2,531 0.55%
Holding current value
$1.9 Million
Previous $2.29 Million 1.62%
% of portfolio
0.31%
Previous 0.34%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $10,809 - $13,440
14 Added 0.55%
2,545 $2.25 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $68,137 - $85,449
94 Added 3.86%
2,531 $2.29 Million
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $293,731 - $392,970
496 Added 25.55%
2,437 $1.9 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $109,764 - $129,398
209 Added 12.07%
1,941 $1.13 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $21,735 - $29,964
50 Added 2.97%
1,732 $930,000
Q2 2023

Jul 20, 2023

BUY
$350.74 - $468.98 $12,275 - $16,414
35 Added 2.13%
1,682 $788,000
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $50,322 - $59,100
162 Added 10.91%
1,647 $565,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $101,931 - $118,770
317 Added 27.14%
1,485 $543,000
Q2 2022

Aug 02, 2022

SELL
$278.73 - $327.27 $433,703 - $509,232
-1,556 Reduced 57.12%
1,168 $379,000
Q1 2022

May 20, 2022

BUY
$234.69 - $291.66 $173,201 - $215,245
738 Added 37.16%
2,724 $780,000
Q4 2021

Feb 23, 2022

SELL
$224.85 - $279.04 $221,477 - $274,854
-985 Reduced 33.15%
1,986 $549,000
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $180,752 - $233,992
1,100 Added 58.79%
2,971 $556,000
Q4 2020

May 11, 2021

SELL
$130.46 - $172.63 $10,958 - $14,500
-84 Reduced 4.3%
1,871 $316,000
Q2 2020

Aug 10, 2020

BUY
$136.42 - $164.18 $27,283 - $32,836
200 Added 11.4%
1,955 $321,000
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $187,644 - $232,414
1,755 New
1,755 $231,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cornerstone Advisory, LLC Portfolio

Follow Cornerstone Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisory, LLC with notifications on news.